You are here

Industry News

Advamed Smart Brief

March 24, 2017
The acquisition of Torax Medical, which makes the Linx acid reflux treatment system for patients with gastroesophageal reflux -More
March 24, 2017
An initial public offering of 5.25 million shares of common stock has been priced by Valeritas with the goal of securing $52. -More
March 24, 2017
An underwritten public offering of common stock has been priced by Tandem Diabetes Care in hopes of obtaining $22.5 million.  -More
March 24, 2017
A private placement of common stock, Series A convertible preferred stock and warrants has brought in approximately $18.9 mil -More
March 24, 2017
A Grand View Research report predicts the worldwide sports medicine market will hit $12.5 billion by 2025 with a 7.7% compoun -More
March 24, 2017
Health Canada has given InVivo Therapeutics approval to conduct a trial of its neuro-spinal scaffold for treating acute, comp -More
March 24, 2017
FusionVu, a combination of microultrasound and MRI, has been introduced by Exact Imaging.  -More
March 24, 2017
The FDA has granted Alcon clearance for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens with Activefocus optical -More
March 24, 2017
European regulators have given HTG Molecular Diagnostics CE mark approval for its HTG EdgeSeq ALKPlus Assay EU, which is inte -More
March 24, 2017
Health Canada has given Zoll Medical approval for its Zoll AED 3 and Zoll AED 3 BLS automated external defibrillators, which  -More

Industry News

Fox Business
Mar. 09, 2017 - AdvaMed CEO Scott Whitaker discusses the impact of the medical device tax on business.​​​​​​
Neurosurgery Blog
Creating life-changing innovations is central to the role the medical technology industry plays in improving patient care. For people with neurological conditions — like spina bifida, epilepsy, Parkinson’s, multiple sclerosis and many others — advances in medical technology are not only improving, but also saving lives. Unbeknownst to many, however, is how one harmful tax policy is creating unnecessary barriers to future advances, and negatively affecting those living with chronic diseases and...
Fox Business
AdvaMed CEO Scott Whitaker on the impact of Obamacare and its medical device tax. ​​​​
Wisconsin State Journal
The United States has long been a leader in medical technology innovation and discovery, and Wisconsin has been a leading state in medical breakthroughs and medical device manufacturing. Unfortunately, we have tax policies, including the medical device tax, that have stifled innovation and job creation, putting our research and technological leadership at risk.
The Journal Gazette
From artificial joints to replacement heart valves, hospital beds to radiation therapies, the economic and human impact of medical technology innovation cannot be overstated. Medical technology companies that innovate quickly and at high levels of quality create and sustain well-paying jobs and, most importantly, save and improve the lives of patients. And that is why permanent repeal of the medical device tax must be a priority for the 115th Congress in 2017. The 2.3 percent excise tax on...